Narrative Update • Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 06, 2026
DataAggregated Company Financials
Companies6
- 7D-0.8%
- 3M-18.9%
- 1Y-28.5%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 3.7%, driven by gains from Alibaba Health Information Technology of 0.6%. In contrast, the industry has lost 27% in the last 12 months. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 06 Aug 2026 | HK$203.6b | HK$143.7b | HK$8.7b | 31.9x | 23.3x | 1.4x |
| Sat, 04 Jul 2026 | HK$187.5b | HK$143.0b | HK$8.7b | 29.8x | 21.5x | 1.3x |
| Mon, 01 Jun 2026 | HK$204.3b | HK$143.2b | HK$8.7b | 34.7x | 23.4x | 1.4x |
| Wed, 29 Apr 2026 | HK$242.1b | HK$140.3b | HK$8.6b | 42.3x | 28.1x | 1.7x |
| Fri, 27 Mar 2026 | HK$259.1b | HK$140.1b | HK$8.3b | 47x | 31.2x | 1.8x |
| Sun, 22 Feb 2026 | HK$315.6b | HK$129.4b | HK$6.9b | 44.8x | 45.6x | 2.4x |
| Tue, 20 Jan 2026 | HK$361.3b | HK$128.1b | HK$6.9b | 49.1x | 52.7x | 2.8x |
| Thu, 18 Dec 2025 | HK$306.2b | HK$126.3b | HK$6.8b | 40x | 45.3x | 2.4x |
| Sat, 15 Nov 2025 | HK$356.1b | HK$122.6b | HK$6.2b | 60.7x | 57.8x | 2.9x |
| Mon, 13 Oct 2025 | HK$346.9b | HK$122.1b | HK$6.1b | 64.1x | 56.5x | 2.8x |
| Wed, 10 Sep 2025 | HK$387.6b | HK$122.4b | HK$6.2b | 73.5x | 63x | 3.2x |
| Fri, 08 Aug 2025 | HK$282.6b | HK$115.4b | HK$4.5b | 51x | 62.7x | 2.4x |
| Sun, 06 Jul 2025 | HK$229.6b | HK$115.6b | HK$4.5b | 43.3x | 50.9x | 2x |
| Tue, 03 Jun 2025 | HK$223.7b | HK$115.0b | HK$4.5b | 46.5x | 49.8x | 1.9x |
| Thu, 01 May 2025 | HK$226.1b | HK$110.3b | HK$4.2b | 62.9x | 54.4x | 2.1x |
| Sat, 29 Mar 2025 | HK$209.1b | HK$110.6b | HK$4.2b | 59.7x | 50.1x | 1.9x |
| Mon, 24 Feb 2025 | HK$239.6b | HK$104.1b | HK$3.6b | 58.5x | 66.5x | 2.3x |
| Wed, 22 Jan 2025 | HK$164.0b | HK$103.8b | HK$3.6b | 39x | 45.6x | 1.6x |
| Fri, 20 Dec 2024 | HK$156.7b | HK$103.5b | HK$3.6b | 37.6x | 43.7x | 1.5x |
| Sun, 17 Nov 2024 | HK$170.6b | HK$104.6b | HK$3.6b | 39.1x | 47.1x | 1.6x |
| Tue, 15 Oct 2024 | HK$181.8b | HK$105.4b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Thu, 12 Sep 2024 | HK$133.9b | HK$105.1b | HK$3.3b | 36x | 40.2x | 1.3x |
| Sat, 10 Aug 2024 | HK$140.3b | HK$103.1b | HK$2.4b | 42.1x | 58.1x | 1.4x |
| Mon, 08 Jul 2024 | HK$137.7b | HK$101.9b | HK$2.4b | 41.8x | 57.7x | 1.4x |
| Wed, 05 Jun 2024 | HK$158.3b | HK$102.3b | HK$2.4b | 47.2x | 66x | 1.5x |
| Fri, 03 May 2024 | HK$168.9b | HK$103.6b | HK$2.3b | 50.6x | 72.6x | 1.6x |
| Sun, 31 Mar 2024 | HK$158.8b | HK$104.0b | HK$2.3b | 47.9x | 68x | 1.5x |
| Tue, 27 Feb 2024 | HK$175.6b | HK$105.1b | -HK$1,455,642,735.76 | 58.1x | -120.7x | 1.7x |
| Thu, 25 Jan 2024 | HK$167.9b | HK$106.7b | -HK$1,479,022,501.00 | 53.4x | -113.5x | 1.6x |
| Sat, 23 Dec 2023 | HK$198.3b | HK$106.0b | -HK$1,468,624,638.00 | 61.2x | -135x | 1.9x |
| Mon, 20 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,792,415.00 | 86.2x | -120.6x | 2.1x |
| Wed, 18 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Fri, 15 Sep 2023 | HK$228.1b | HK$102.8b | -HK$1,682,295,105.00 | 84.3x | -135.6x | 2.2x |
| Sun, 13 Aug 2023 | HK$269.5b | HK$95.6b | -HK$4,146,464,127.00 | 124.6x | -65x | 2.8x |
Price to Earnings Ratio
-65x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.2x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 15% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -0.38% | |
| Consumer Staples | -3.54% | |
| Food and Staples Retail | -1.26% | |
| Drug Retail | -0.82% | |
| Food Distributors | 4.92% | |
| Food Retail | -2.03% | |
| Big Box Super Stores | -5.37% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6086 Fangzhou | HK$0.72 | 6.6% +HK$62.3m | -80.4% | PE73.1x | |
| 314 Sipai Health Technology | HK$1.39 | 3.0% +HK$29.1m | -77.3% | PS0.4x |